CA2182105A1 - Chloropyrimide intermediates - Google Patents
Chloropyrimide intermediatesInfo
- Publication number
- CA2182105A1 CA2182105A1 CA002182105A CA2182105A CA2182105A1 CA 2182105 A1 CA2182105 A1 CA 2182105A1 CA 002182105 A CA002182105 A CA 002182105A CA 2182105 A CA2182105 A CA 2182105A CA 2182105 A1 CA2182105 A1 CA 2182105A1
- Authority
- CA
- Canada
- Prior art keywords
- intermediates
- chloropyrimide
- processes
- iii
- aminopurines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Abstract
The present invention relates to certain novel pyrimidine intermediates of formulae I, II and III indicated hereinafter and their salts, processes for their preparation and processes for their conversion to 9-substituted-2-aminopurines which are useful in medical therapy:
(see figure I, II, III)
(see figure I, II, III)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9402161A GB9402161D0 (en) | 1994-02-04 | 1994-02-04 | Chloropyrimidine intermediates |
GB9402161.5 | 1994-02-04 | ||
PCT/GB1995/000225 WO1995021161A1 (en) | 1994-02-04 | 1995-02-03 | Chloropyrimide intermediates |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2182105A1 true CA2182105A1 (en) | 1995-08-10 |
CA2182105C CA2182105C (en) | 2006-07-25 |
Family
ID=36707428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002182105A Expired - Lifetime CA2182105C (en) | 1994-02-04 | 1995-02-03 | Chloropyrimide intermediates |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2182105C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117050024A (en) * | 2023-10-13 | 2023-11-14 | 苏州开元民生科技股份有限公司 | Synthesis method of 2-amino-4, 6-dichloro-5-formamidopyrimidine |
-
1995
- 1995-02-03 CA CA002182105A patent/CA2182105C/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117050024A (en) * | 2023-10-13 | 2023-11-14 | 苏州开元民生科技股份有限公司 | Synthesis method of 2-amino-4, 6-dichloro-5-formamidopyrimidine |
CN117050024B (en) * | 2023-10-13 | 2024-01-05 | 苏州开元民生科技股份有限公司 | Synthesis method of 2-amino-4, 6-dichloro-5-formamidopyrimidine |
Also Published As
Publication number | Publication date |
---|---|
CA2182105C (en) | 2006-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL112539A0 (en) | Pyrimidine derivatives and their preparation | |
CA2201785A1 (en) | New carboxylic acid derivatives, their preparation and their use | |
HK1066010A1 (en) | Optically active compounds which are useful as intermediates in the preparation of optically acitve-2-imidazoline-5-thione derivatives | |
AU5304094A (en) | Intermediates useful in the preparation of 7-azaisoindolinyl-quinolone- and-naphthyridonecarboxylic acid derivatives | |
MY115679A (en) | Process for preparing intermediates to florfenicol | |
CA2311922A1 (en) | Thienopyrimidines | |
IL132599A0 (en) | Substituted 3,3-diamino-2-propenenitriles their preparation and use | |
AU4912090A (en) | Intermediates useful in the synthesis of 2-oxy-4h-3, 1-benzoxazin-4-one derivative | |
CA2219359A1 (en) | Hydantoin derivatives as intermediates for pharmaceutical active compounds | |
CA2182105A1 (en) | Chloropyrimide intermediates | |
CA2208630A1 (en) | 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use | |
AU2253088A (en) | Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation | |
AU6922994A (en) | Use of acylcarnitin to treat illnesses caused by aids | |
IL140786A0 (en) | Process for the preparation of 4,6-disubstituted 2-isocyanatopyrimidines and their use as intermediates for active compound syntheses | |
CA2208611A1 (en) | 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use | |
HUT71549A (en) | Process for producing pharmaceutical active 4-hydroxy 1h-pyrazolo [3,4d] pyrimidine of high purity | |
AU4448497A (en) | Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents | |
IL111770A0 (en) | Triarylborane derivatives, their preparation and their use as synthesis intermediates | |
CA2155802A1 (en) | Enantiomerically pure pyridylcycloalkylethylamines and the salts thereof and processes for preparing them | |
ITMI942632A0 (en) | PROCEDURE FOR THE PREPARATION OF HIGH PURITY 3 ALPHA-7 BETA-DIHYDROXYCHOLANIC ACID | |
PL309329A1 (en) | Novel triazopyrimidones, methods of obtaining them and their application | |
IT1289503B1 (en) | HIGH PURITY PROCEDURE FOR THE PREPARATION OF 3 ALPHA-7 BETA-DIHYDROXICOLANIC ACID |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20150203 |